Genetic Predisposition for Nonmedullary Thyroid Cancer

被引:0
作者
Rebecca Nagy
Matthew D. Ringel
机构
[1] The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute,Divison of Human Genetics
[2] The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center and Richard G. Solove Research Institute,Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine
[3] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Human Genetics
[4] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Endocrinology, Metabolism and Diabetes
来源
Hormones and Cancer | 2015年 / 6卷
关键词
Thyroid Cancer; Papillary Thyroid Carcinoma; Familial Adenomatous Polyposis; Papillary Thyroid Cancer; Differentiate Thyroid Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Nonmedullary thyroid cancer (NMTC) can be sporadic or can occur as a component cancer as part of several well-described hereditary cancer syndromes. NMTC, particularly papillary thyroid cancer, also can occur by itself in families and is often termed familial NMTC or familial papillary thyroid cancer. The occurrence of NMTC in families, along with extensive population-based evidence from patients with sporadic thyroid cancer, together suggest that NMTC has a strong genetic component, only a small proportion of which has been characterized to date. Advances in genetic and genomic technology have rapidly advanced our understanding of the complex nature of NMTC susceptibility, although much remains to be explained. Herein, we describe the current state of knowledge, starting with a brief review of hereditary syndromic causes and moving on to describe recent data using modern genomic approaches to identifying genes involved in the predisposition to NMTC.
引用
收藏
页码:13 / 20
页数:7
相关论文
共 78 条
[1]  
Chen AY(2009)Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 Cancer 115 3801-3807
[2]  
Jemal A(2007)Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident Health Phys 93 502-511
[3]  
Ward EM(1980)Radiation and host factors in human thyroid tumors following thymus irradiation Health Phys 38 451-465
[4]  
Ron E(2010)Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the hempelmann cohort Radiat Res 174 753-762
[5]  
Shore RE(2013)Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma J Clin Endocrinol Metab 98 3039-3048
[6]  
Adams MJ(2013)Diagnosis and management of differentiated thyroid cancer using molecular biology Laryngoscope 123 1059-1064
[7]  
Reiners C(2004)Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family PLoS Med 1 e65-788
[8]  
Witt RL(1989)Papillary thyroid carcinoma in Iceland. A study of the occurrence in families and the coexistence of other primary tumours Acta Oncol 28 785-1608
[9]  
Amundadottir LT(1994)Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands J Natl Cancer Inst 86 1600-150
[10]  
Hrafnkelsson J(2001)Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families Int J Cancer 92 144-117